The Danish agricultural company Agromino with assets in Ukraine, the Russian Federation and Estonia saw EUR 2.66 million in net profit in 2019 compared with EUR 9.55 million of net loss in 2018.
According to a company report on its website, total revenue in 2019 grew by 40.9%, to EUR 35.62 million.
Agromino in 2019 saw EUR 9.9 million of earnings before interest, taxes, depreciation and amortization (EBITDA) compared with EBITDA loss of EUR 7.6 million in 2018.
“A significant change in net loss in 12m 2019 in comparison with 12m 2018 was due to absence of currency translation losses from disposal of subsidiaries (EUR 10 million loss in 12m 2018),” the company said.
Consolidated assets as of late 2019 amounted to EUR 113.57 million (EUR 46.56 million by late 2018).
Total storage capacity increased to 121,000 tonnes due to setting up new elevator capacities in the group (85,000 tonnes as of 31 December 2018). Total land under control as at December 31, 2019 was 55,500 hectares (47,000 hectares at December 31, 2018). The increase was due to acquisition of Resilient a.s.
The company said that crop harvest in 2019 completed with satisfactory results, mainly due to 31% increase in average net yield to 3.54 t/ha (2.70 t/ha in 2018). Combined harvest of the group including Resilient has reached 198,000 tonnes brutto Agromino itself harvested 156,000 brutto tonnes compared to 124,000 brutto tonnes in 2018.
Wheat on 18,900 ha and oilseed rape on 4,900 0 ha as of December 31, 2019 are in reasonable condition.
National bank of Ukraine’s official rates as of 02/03/20
Source: National Bank of Ukraine
Official rates of banking metals from national bank as of March 02
One troy ounce=31.10 grams
What factors affecting the pharmaceutical companies in 2020? What important signals and triggers for action does the market show? How to maintain balance in turbulence? Which way to choose – confrontation, opposition or adaptation to external factors?
2020 will be unique year for the healthcare sector of Ukraine. From April 1st, 2020, the National Healthcare Service of Ukraine (NHSU) will start paying for medical services at the secondary and tertiary levels of care. At the moment, it is difficult to predict the progress and implementation of the reform in 2020. Much more information will appear in March, closer to the date of the Ukrainian Pharmaceutical Congress.
The Congress agenda is developed by experts in the field of pharmaceuticals and legal regulation of the industry specifically for top managers of pharmaceutical companies. This is an opportunity to learn about innovations and recent changes in pharmaceuticals and receive practical information for making strategic decisions necessary for the successful operation of pharmaceutical companies in Ukraine.
Get a fresh perspective on:
-MEDICAL REFORM: current state and influence on the pharmaceutical industry in 2020-2021
-PROCUREMENT AND REIMBURSEMENT: what road signs point on – innovations and consequences
-COMPETITION ON THE PHARMACEUTICAL MARKET: the great battle or moderate struggle?
-INDUSTRY INSIGHTS and EXCLUSIVE CASES: challenges and predictions
The Congress is attended by leading experts in the field of pharmaceuticals and legal support, professionals in the field of medicine and healthcare, representatives of state bodies, top managers of leading national and international pharmaceutical companies, representatives of healthcare facilities, professional associations, state authorities in the healthcare sector and parliamentarians.
In particular, representatives of the Verkhovna Rada Committee on National Health, Medical Assistance and Medical Insurance, the Ministry of Health of Ukraine, the State Health Service of Ukraine, Electronic Health state-owned enterprise, State Medical Procurement of Ukraine state-owned enterprise, multidisciplinary hospitals and pharmaceutical companies have been invited to discuss the latest changes and prospects for the industry.
PROGRAM & REGISTRATION
https://www.legalalliance.com.ua/eng/events/ukrainian-pharmaceutical-congress-2020/
Join the important event for key pharmaceutical managers on March 19th and make a successful investment in improving the efficiency of your business!
Organizers:
Legal Alliance Company
ABSC Consulting Company
General Information Partner:
Interfax-Ukraine
Location: Ramada Encore Kiev, Stolychne Hwy 103
Congress working languages: Ukrainian, Russian. Simultaneous interpretation into English
Organizational partner: Pravotoday LLC Info Agency
Event-partner: GB17 – Garden of Brands
Participant registration and mass media accreditation: news@l-a.com.ua
The enterprises of Ukroboronprom concern exported $908 million worth of arms and services abroad in 2019, which is 19% more than a year earlier, said Aivaras Abromavicius, the head of the Ukroboronprom state concern. “Last year, our companies exported arms and services worth $908 million. This is a 19% increase over the previous year,” the head of the concern said on the Real Politics program on Ukraine 24 TV channel on Sunday.
Abromavicius added that Ukraine is not one of the ten largest arms exporters, while U.S. and Russian exports are ten times greater than domestic, but assured that Ukroboronprom’s foreign supply will also increase in 2020.
“We see that in 2020 export growth is planned to reach 30%. And this is a very important figure, especially in anticipation of a slowdown in industrial production growth, which is taking place not only in our country, but throughout the world,” said the head of Ukroboronprom.
